Jump to content

Recommended Posts

Posted
And the EliteXC failure was a big one

 

Antonio Silva Jr., the current EliteXC Heavyweight Champion, tested positive for Boldenone. He has been suspended for one year and fined $2,500.

 

F4W

 

Update on Silva drug test failure

 

Despite Antonio Silva's drug test failure his victory over Justin Eilers on the July 26th EXC show in Stockton will stand, said Bill Douglas of the California State Athletic Commission.

 

The regulations package which includes changes of decision due to drug test failures is currently in the Department of Finance, the last stop before heading to the Office of Administrative Law and the Secretary of State. "We're almost there," Douglas said, "but we can't do anything result-wise retroactively."

 

According to sources in Pro Elite, Silva will be filing an appeal.

 

F4W

 

Things were going bad for EliteXC out of the cage, and now this. I'm sure there's an MMA conspiracy theorist out there wondering why no major/semi-major UFC names fail the tests, James Irvin not withstanding.

Posted
I'm sure there's an MMA conspiracy theorist out there wondering why no major/semi-major UFC names fail the tests, James Irvin not withstanding.

 

Ever heard of Sean Sherk?

 

Who wants to bet that Brett Rogers Vs. Kimbo Slice will be for the vacant HW title?

Posted
Sylvia as well, but that was ages ago.

A better way of putting it would have been that the timing, at least to the conspiracy theorist, is strange that just when UFC is starting to get some competition from EliteXC, their heavyweight champion just happens to fail a test. Presumably, Silva would have been one of the non-Kimbo Slice names that EliteXC would have built their promotional machine around, and now he's out of the picture for a year.

 

Irvin failed a test, but he's not a major name. And while Sherk failed too, and was Lightweight champion, he wasn't a major name at the time.

Please sign in to comment

You will be able to leave a comment after signing in



Sign In Now
×
×
  • Create New...